Reaching toward the future

Mary Crowley Cancer Research works to find potentially curative treatments for cancer patients through clinical trial testing.  Our patient-specific approach uniquely aligns an individual’s cancer with the newest discoveries in personalized genomic and immune therapies.  Mary Crowley advances science and HOPE for cancer patients worldwide.

“We don’t build a lot of buildings and parking lots and things like that, we use the money raised for patients so they can receive the newest investigational cancer options"

Dr. John Nemunaitis, Executive Medical Director

Our Mission

The mission of Mary Crowley Cancer Research is to expand treatment options for all cancer patients through investigational vaccine, gene, and cellular therapies.

While our ultimate goal is to cure our patients’ cancer, our ongoing objective is to provide novel agents in innovative ways, thereby transforming cancer into a manageable condition for patients while maintaining their quality of life.  We strive to apply these investigational and innovative therapies early in the course of a patient’s disease where its effect can be optimized and prevent disease recurrence.

Click HERE for our Core Values

Biennial Reports

2014-2015 Biennial Report

2014-2015 Biennial Report

2012-2013 Biennial Report

2012-2013 Biennial Report

2010-2011 Biennial Report

2010-2011 Biennial Report